As used herein, a hybrid factor VIII equivalent molecule or fragment thereof or hybrid equivalent factor VIII or fragment thereof is an active factor VIII or hybrid factor VIII molecule or fragment thereof comprising at least one sequence including one or more amino acid residues that have no known identity to human or animal factor VIII sequence substituted for at least one sequence including